Table 1.

Baseline characteristics of patients (n = 159).

Baseline Characteristics	N (%) or Median (IQR)
Age (years)	70 (60–77)
Male gender	107 (67%)
CAP	105 (66%)
HAP	54 (34%)
Ward of admission
Internal Medicine	49 (30%)
Hematology	29 (18%)
Emergency Medicine	19 (12%)
Cardiology	15 (9%)
Geriatrics	6 (4%)
Respiratory Medicine	5 (4%)
Other	36 (23%)
COVID-19 pneumonia	30 (19%)
Immunedepressed patients	74 (46%)
Hematological disease	33 (21%)
Immunomodulatory drugs	12 (8%)
Solid organ transplant	12 (8%)
Chemotherapy	15 (9%)
HIV	2 (1%)
Baseline risk factors for MRSA
None	12 (7.5%)
At least one	147 (92.5%)
Colonization	9 (6%)
Previous infection	8 (5%)
Gram positive cocci on sputum/BAL	34 (21%)
Recent influenza	32 (20%)
Previous hospitalization within 90 days	90 (56%)
Necrotizing pneumonia	5 (4%)
Empyema	6 (4%)
Immunedepression	74 (46%)
Dialysis	2 (1%)
Blood cultures
Positive	33 (21%)
Negative	126 (79%)
Not performed	0 (0%)
Broncho alveolar lavage
Positive	20 (13%)
Negative	37 (8%)
Not performed	102 (79%)
Sputum
Positive	5 (3%)
Negative	15 (9%)
Not performed	139 (88%)
Urinary antigen for S. pneumoniae and Legionella pneumophilia
Positive	5 (3%)
Negative	136 (86%)
Not performed	18 (11%)
Nasal swab for MRSA
Positive	3 (2%)
Negative	45 (28%)
Not performed	111 (70%)
Rectal swab for ESBL or CPE
Positive	12 (8%)
Negative	70 (44%)
Not performed	77 (48%)
CURB65 in CAP
0–1	93 (58%)
2	52 (32%)
≥3	14 (9%)
PSI in CAP
I/II	8 (5%)
III	8 (5%)
IV	55 (34%)
V	55 (34%)
Pitt score
<4	122 (77%)
≥4	37 (23%)
Charlson Comorbidity Index (CCI)	5 (3–7.5)
INCREMENT-ESBL Score	8 (6–11)
0–8	74 (46%)
11–14	80 (50%)
>15	5 (3%)